Bio-Path (NASDAQ:BPTH) Coverage Initiated by Analysts at StockNews.com
StockNews.com initiated coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a research note issued to investors on Sunday. The firm issued a sell rating on the stock. Bio-Path Price Performance NASDAQ BPTH opened at $0.15 on Friday. Bio-Path has a fifty-two week low of $0.12 and a fifty-two week high of $4.55. The […]
StockNews.com initiated coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a research note issued to investors on Sunday. The firm issued a sell rating on the stock. Bio-Path Price Performance NASDAQ BPTH opened at $0.15 on Friday. Bio-Path has a fifty-two week low of $0.12 and a fifty-two week high of $4.55. The […]
